Disease landscape

Atopic Dermatitis clinical trials

Get alerts when Atopic Dermatitis trials change

328 active trials 172 recruiting 51 Phase 3 211 sponsors 69 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days showing 45 of 69 changes on 19 trials

2026-08-29
Trial terminated
Trial terminated: Recruitment targets (sample size) could not be met within the planned time frame.
Primary completion 2026-06-30, 181 days after the final estimate of 2025-12-31
Final enrollment: 210 participants (planned 240)
NCT06937788 Replication of the Heads Up Atopic Dermatitis Trial With Registry Data · Technische Universität Dresden
2026-09-05
Primary completion pushed: 2026-07-10 → 2027-01-20
Primary endpoint(s) modified
Phase changed: Phase 2 → Phase 2/3
Enrollment increased: 110 → 190 participants
Completion pushed: 2026-07-10 → 2027-01-20
NCT07355075 A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and… · Turn Therapeutics · Phase 2/3
2026-09-01
Primary completion pushed: 2026-03-31 → 2026-12-31
Completion pushed: 2026-03-31 → 2026-12-31
NCT06468956 Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic… · Guangdong Hengrui Pharmaceutical Co., Ltd · Phase 3
2026-08-29
Primary completion pushed: 2026-10 → 2027-10
Completion pushed: 2026-12 → 2027-12
NCT06487000 Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to… · Enzychem Lifesciences Corporation · Phase 2
2026-08-28
Primary completion pushed: 2025-10-30 → 2028-02-17
Recruitment opened
Completion pushed: 2025-12-30 → 2028-03-30
NCT06931990 A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158… · Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Phase 1/2
2026-08-28
Primary completion pushed: 2025-03-31 → 2025-11-25
Trial completed
Enrollment increased: 127 → 150 participants
Completion pushed: 2025-06-01 → 2025-11-25
NCT06082323 A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult… · Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Phase 1
2026-08-07
Primary completion pushed: 2029-11 → 2030-07
Completion pushed: 2029-11 → 2030-07
NCT06461897 A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral… · AbbVie · Phase 3
2026-08-14
Primary endpoint(s) modified
Enrollment increased: 150 → 230 participants
NCT06192563 A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less… · Sanofi
2026-08-25
Primary endpoint(s) modified
NCT07746427 Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis · Weill Medical College of Cornell University
2026-09-05
Recruitment opened
Interventions modified
Trial sites expanded: 0 → 3 locations
NCT07765888 A Study to Learn About the Study Medicine Called Tilrekimig in People With… · Pfizer · Phase 3
2026-09-04
Trial completed
Primary completion confirmed: August 2026 (last estimated December 2026)
NCT06468956 Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic… · Guangdong Hengrui Pharmaceutical Co., Ltd · Phase 3
2026-09-02
Trial completed
NCT06554847 Evaluation of 611 in Combination With Topical Corticosteroid in Participants With… · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Phase 3
2026-08-28
Recruitment opened
NCT07370909 Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients… · Shanghai Longwood Biopharmaceuticals Co., Ltd. · Phase 3
2026-08-18
Recruitment opened
NCT07542483 A Study of Lebrikizumab in Adults With Nummular Eczema · Almirall, S.A. · Phase 3
2026-08-13
Enrollment closed, study ongoing
Primary completion moved earlier: 2028-01 → 2027-08
Completion moved earlier: 2028-01 → 2027-08
NCT07265479 A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3… · Organon and Co · Phase 3
2026-08-25
Trial completed
Primary completion pushed: 2026-04 → 2026-06-26
Completion pushed: 2026-04 → 2026-06-26
NCT07264335 A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using… · Guangdong Hengrui Pharmaceutical Co., Ltd · Phase 1
2026-08-15
Recruitment opened
NCT07660835 Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months… · Galderma R&D · Phase 2
2026-08-14
Recruitment opened
NCT07560618 Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over… · Integrative Skin Science and Research · Phase 4
2026-08-07
Recruitment opened
Trial sites expanded: 1 → 9 locations
NCT07643766 A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults… · Enveda Therapeutics · Phase 2
2026-08-09
Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University → Second Affiliated Hospital, Zhejiang University, School of Medicine
Trial status changed: Not Yet Recruiting → Unknown
NCT06465732 Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe… · Second Affiliated Hospital, School of Medicine, Zhejiang University · Phase 4

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-09-04 NCT07804134 Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring… Medisch Spectrum Twente new
2026-09-02 NCT07800104 Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe… QuantX Biosciences, Inc. new Phase 1
2026-08-10 NCT07754968 Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic… University of Roma La Sapienza new
2026-08-05 NCT07746817 A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic… Bionyra Pharma new Phase 1
2026-08-05 NCT07746427 Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis Weill Medical College of Cornell University new
2026-08-04 NCT07744516 Clinical Trial to Evaluate the Efficacy and Safety of an Ozonated Oil in Atopic Dermatitis Laboratorios Ozoaqua new
2026-08-03 NCT07742241 Efficacy Study of a Repairing Cream in Atopic Dermatitis Instituto de Investigacion Biotecnologica, Farmaceutica y Medicamentos Huerfanos, S.L. new
2026-07-17 NCT07712536 Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent… E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. new Phase 2
2026-07-14 NCT07701447 Efficacy and Tolerability of a Probiotic Ointment BioGaia AB new
2026-07-14 NCT07703215 NPQ Plus Supplementation for Skin Health and Antioxidant Status N REMEDIER (M) SDN BHD new

Active trials by phase

Early Phase 1
1
Phase 1
33
Phase 1/2
4
Phase 2
60
Phase 2/3
4
Phase 3
47
Phase 4
21
Not charted: 158 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 328

NCT IDTitleSponsorStatusUpdated
Phase 4
NCT07560618 Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over… Integrative Skin Science and Research Recruiting 2026-08-13
NCT05858619 Molecular Signatures of Cutaneous Dupilumab Response University of California, San Francisco Recruiting 2026-06-04
NCT05042258 Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With… Northwestern University Recruiting 2026-04-27
NCT06116526 Dupilumab De-escalation in Pediatric Atopic Dermatitis Johns Hopkins University Recruiting 2026-04-20
NCT05268107 Ethnic Differences in Mechanisms of Action of Dupilumab University of Michigan Recruiting 2025-11-06
NCT06004986 DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Recruiting 2025-10-08
NCT06906497 Lebrikizumab in Moderate-to-severe Atopic Dermatitis Johann E Gudjonsson MD PhD Recruiting 2025-08-11
NCT05758532 Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and… Laure Pittet, MD-PhD Recruiting 2024-05-29
NCT05285839 Dupixent and Narrowband UVB for Atopic Dermatitis Psoriasis Treatment Center of Central New Jersey Recruiting 2024-03-15
NCT07661979 Opzelura Experience Study Wake Forest University Health Sciences Not Yet Recruiting 2026-09-04
NCT07713186 Azithromycin in Atopic Dermatitis Cairo University Not Yet Recruiting 2026-07-20
NCT07447063 The Impact of Dietary Salt on the Severity of Eczema University of California, San Francisco Not Yet Recruiting 2026-06-09
NCT07487831 The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease University of California, San Francisco Not Yet Recruiting 2026-06-09
NCT07352566 Utilization of a Microdevice for Psoriasis and Atopic Dermatitis University of California, San Francisco Not Yet Recruiting 2026-06-03
NCT07006792 A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic… Eli Lilly and Company Active, Not Recruiting 2026-05-22
NCT06397781 Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients Boston Children's Hospital Not Yet Recruiting 2026-03-10
NCT07438509 Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema Jinnah Postgraduate Medical Centre Not Yet Recruiting 2026-03-06
NCT05566262 Bodewell Products for the Treatment of Atopic Dermatitis University of Alabama at Birmingham Active, Not Recruiting 2026-03-02
NCT07437534 Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%)… Hayat Abad Medical Complex, Peshawar Not Yet Recruiting 2026-03-02
NCT07367932 Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis Cairo University Not Yet Recruiting 2026-01-26
NCT05642208 Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With… Nantes University Hospital Active, Not Recruiting 2025-09-11
Phase 3
NCT06807268 A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age… Pfizer Recruiting 2026-09-04
NCT06807281 A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older… Pfizer Recruiting 2026-09-04
NCT07765888 A Study to Learn About the Study Medicine Called Tilrekimig in People With… Pfizer Recruiting 2026-09-04
NCT07370909 Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients… Shanghai Longwood Biopharmaceuticals Co., Ltd. Recruiting 2026-08-27
See all 328 active Atopic Dermatitis trials with filters →

Top sponsors by active trials in this area

Pfizer (12) · AbbVie (10) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Sanofi (7) · Keymed Biosciences Co.Ltd (5) · University of California, San Francisco (5) · Eli Lilly and Company (4) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (4) · Galderma R&D (4) · Innovent Biologics (Suzhou) Co. Ltd. (4)

Get alerts when Atopic Dermatitis trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free